Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade F 139.07 0.29% 0.40
AGN closed up 0.29 percent on Friday, February 15, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical AGN trend table...

Date Alert Name Type % Chg
Feb 15 Narrow Range Bar Range Contraction 0.00%
Feb 15 Multiple of Ten Bearish Other 0.00%
Feb 14 Narrow Range Bar Range Contraction 0.29%
Feb 14 NR7 Range Contraction 0.29%
Feb 13 1,2,3 Retracement Bearish Bearish Swing Setup -0.90%
Feb 13 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.90%
Feb 13 Multiple of Ten Bullish Other -0.90%
Feb 13 Up 3 Days in a Row Strength -0.90%
Feb 13 Oversold Stochastic Weakness -0.90%
Feb 12 Gapped Up Strength 0.19%

Older signals for AGN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Medicine Medical Specialties Life Sciences Pharmaceutical Surgery Pharmaceutical Products Inflammation Infection Psoriasis Medical Devices Acne Glaucoma Allergy Medical Device Skin Care Products Ophthalmic Products Breast Implant Breast Implants Over The Counter Products Retinal Disease Allergan Bausch Health Food Stores
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 197.0
52 Week Low 125.84
Average Volume 3,195,705
200-Day Moving Average 166.3569
50-Day Moving Average 144.6608
20-Day Moving Average 145.1225
10-Day Moving Average 136.966
Average True Range 4.1032
ADX 28.77
+DI 23.5883
-DI 29.8595
Chandelier Exit (Long, 3 ATRs ) 148.7204
Chandelier Exit (Short, 3 ATRs ) 142.6596
Upper Bollinger Band 164.9141
Lower Bollinger Band 125.3309
Percent B (%b) 0.35
BandWidth 27.275715
MACD Line -3.0951
MACD Signal Line -2.6559
MACD Histogram -0.4392
Fundamentals Value
Market Cap 46.49 Billion
Num Shares 334 Million
EPS 32.82
Price-to-Earnings (P/E) Ratio 4.24
Price-to-Sales 3.91
Price-to-Book 0.84
PEG Ratio 0.97
Dividend 2.80
Dividend Yield 2.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 141.86
Resistance 3 (R3) 141.92 141.06 141.40
Resistance 2 (R2) 141.06 140.35 141.03 141.24
Resistance 1 (R1) 140.06 139.91 139.63 140.00 141.08
Pivot Point 139.20 139.20 138.98 139.17 139.20
Support 1 (S1) 138.20 138.49 137.77 138.14 137.06
Support 2 (S2) 137.34 138.05 137.31 136.90
Support 3 (S3) 136.34 137.34 136.75
Support 4 (S4) 136.28